A detailed history of Opaleye Management Inc. transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Opaleye Management Inc. holds 420,000 shares of NRIX stock, worth $8.39 Million. This represents 1.72% of its overall portfolio holdings.

Number of Shares
420,000
Previous 418,928 0.26%
Holding current value
$8.39 Million
Previous $8.74 Million 7.85%
% of portfolio
1.72%
Previous 2.24%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$18.93 - $25.69 $20,292 - $27,539
1,072 Added 0.26%
420,000 $9.43 Million
Q2 2024

Aug 14, 2024

BUY
$12.02 - $21.3 $1.82 Million - $3.23 Million
151,718 Added 56.78%
418,928 $8.74 Million
Q1 2024

May 29, 2024

BUY
$7.77 - $15.66 $2.08 Million - $4.18 Million
267,210 New
267,210 $3.93 Million

Others Institutions Holding NRIX

About Nurix Therapeutics, Inc.


  • Ticker NRIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,147,800
  • Market Cap $942M
  • Description
  • Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...
More about NRIX
Track This Portfolio

Track Opaleye Management Inc. Portfolio

Follow Opaleye Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Opaleye Management Inc. with notifications on news.